Integrated Kidney Care of Ohio, LLC
KCE Located In: Ohio
Participant Groups and Providers
RENAL PHYSICIANS INC
AUGUSTUS EDUAFO
NORTHEAST OHIO NEPHROLOGY ASSOCIATES INC
ANDREW CHIAO
CHARINA GAYOMALI
DARRYL ANDERSON
THOMAS KAYANI
VALERIE JORGE CABRERA
XANDER BUENAFE
ADVANCED NEPHROLOGY & HYPERTENSION
M ULLAH
SANJU VARGHESE
KIDNEY & HYPERTENSION CONSULTANTS INC
AMY HAZEL
ANTHONY DEGENHARD
BHAVNISH BUCKTOWARSING
DAYANAND MAKEY
JAMES RAJAN
JOHN GARTON
KEVIN KELLEY
PRAMOD BHARGAVA
TAMMY MICCO
AVITA NEPHROLOGY
NHAN LUU
ADULT HYPERTENSION AND KIDNEY SPECIALISTS LLC
ADELEYE EDON
PIUS KURIAN
SAM MHANNA MD LLC
HOUSSAM MHANNA
TRICIA WILLIAMS
UNIVERSITY OF CINCINNATI
AMIT GOVIL
Preferred Groups and Providers
VILLAGEHEALTH DM LLC
CARRIE TUCKER
DEBORAH COLE
DEIRDRE PERRY
ELIZABETH JOSEPH
KARIN BENNER
LINDSEY YOKUM
SANDRA WAGNER
STEPHANIE WEAVER
SHANAH HAMMOCK
Clinical and Administrative Leadership
Erin Hannah
Primary Contact & Administrative Leader
Director, DaVita IKC
Dayanand Makey
KCE Clinical Leader
K and H - Kidney and Hypertension Consultants (OH)
Quality Measures
Information for the following performance measures will be available by February 1st, 2024.
- The Depression Response measure is a patient-reported outcome measure that assesses the percentage of adult patients (18 years of age or older) who score >9 on the Patient Health Questionnaire (PHQ-9), have a diagnosis of major depression or dysthymia and who demonstrate a response to treatment at approximately 12 months.
- The Patient Activation Measure (PAM) licensed through Insignia Health (a Phreesia company), assesses the attitudes, motivators, and behaviors that allow a patient to manage his or her healthcare issues. Patient activation is essential to achieving improved health outcomes and cost control.
- Optimal ESRD Starts quantifies the ability of healthcare providers to prepare patients for ESRD by educating them and their families about the need for dialysis or kidney transplant, helping them to make appropriate and informed choices about their treatment modality, and supporting them in successfully transitioning to dialysis or kidney transplantation as kidney function declines.
Shared Savings and Losses
Information for the following performance measures will be available by February 1st, 2024.
- Total amount of Shared Savings or Shared Losses per Performance Year
- Proportion of Shared Savings invested in the program and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries
- Proportion of Shared Savings to KCE Participants and Preferred Providers for each Performance Year

For a full list of facilities and joint ventures, please click here.

For more information on CKCC, click here.